Loading...
Market
Will the initial rejection rate of cancer drug prescriptions by payers fall below 70% in 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
IQVIA and healthcare industry reports
Story
CMS Prior Authorization Reforms to Save $15B Amid High Denials
Aug 30, 2024, 06:00 PM
The process of prior authorization in healthcare, a cost-control measure used by health plans, is under scrutiny for delaying patient access to care. The American Medical Association (AMA) has been advocating for reforms, leading to a new requirement for CMS-regulated health plans to offer electronic prior authorizations integrated within electronic health records (EHRs). This change is expected to reduce physician burdens, cut delays for patients, and save $15 billion. Despite these efforts, challenges remain, as evidenced by Medicare Advantage insurance plans denying 3.4 million, or 7.4%, of 46 million prior authorization requests in 2022. Additionally, IQVIA reports that payers initially reject over 75% of cancer drug prescriptions.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 50% • 25%
50% - 60% • 25%
60% - 70% • 25%
More than 70% • 25%
Yes • 50%
No • 50%
Less than 10% • 25%
10%-20% • 25%
20%-30% • 25%
More than 30% • 25%
Yes • 50%
No • 50%
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
Yes • 50%
No • 50%
